A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

August 31, 2016

Conditions
Sickle Cell Disease
Interventions
OTHER

Blood draw

When possible, blood will be drawn as an extra aliquot utilizing the same needle stick procedure performed for standard of care.

OTHER

Nasopharyngeal wash

Nasopharyngeal washes are optional for Group A and Group B participants. Nasopharyngeal washes will be performed on all subjects in Group C. The technique used will be the same as used for regular standard of care per St. Jude guidelines.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT02261480 - A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease | Biotech Hunter | Biotech Hunter